Reduction in urinary MCP-1 levels following treatment preceded the improvement of renal function by a median of 2 weeks; and in one patient, rising urinary levels of MCP-1 were associated with progression to severe renal failure despite immunosuppression. This evidence concerns the gene CCL2 and Renal insufficiency.